Case report: Irreversible, severe congestive cardiomyopathy occurring in association with interferon alpha therapy

Keyphrases

• Interferon-α (IFN-α) 100%
• Congestive Cardiomyopathy 100%
• Interferon alpha Therapy 100%
• Cardiomyopathy 25%
• Doxorubicin 25%
• Interferon Therapy 25%
• Etiology 12%
• Antitumor Activity 12%
• Hematological Malignancies 12%
• Life-threatening 12%
• Multiple Myeloma 12%
• Cardiovascular Effects 12%
• Myocytes 12%
• Fever 12%
• Intracellular Lipid Accumulation 12%
• Acute Toxicity 12%
• Malaise 12%
• Myalgia 12%
• Endomyocardial Biopsy 12%
• Cardiac Toxicity 12%
• Anthracyclines 12%
• Nausea-vomiting 12%
• Tachycardia 12%
• Anthracycline-induced Cardiotoxicity 12%
• Solid Malignancies 12%
• Dizziness 12%
• Biological Agents 12%
• Cause-effect Relationship 12%
• Hypotension 12%
• Cardiotoxicity 12%
• Cardiac Dysfunction 12%
• Anorexia 12%
• Rare Complication 12%
• Bone Marrow Suppression 12%
• Flu-like 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Interferon 100%
• Alpha Interferon 100%
• Congestive Cardiomyopathy 100%
• Cardiotoxicity 42%
• Anthracycline 28%
• Doxorubicin 28%
• Myocardial Disease 28%
• Neoplasm 14%
• Nausea 14%
• Multiple Myeloma 14%
• Biological Product 14%
• Tachycardia 14%
• Acute Toxicity 14%
• Malaise 14%
• Myalgia 14%
• Bone Marrow Suppression 14%
• Flu Like Syndrome 14%
• Dizziness 14%
• Anorexia 14%
• Hypotension 14%
• Chill 14%